New Pugatch Consilium report finds Colombia could see over 100 new clinical trials and up over $450 million in economic gains per year with policy reform

Posted by:

Today Pugatch Consilium releases Challenges and Opportunities – Developing the Biotechnology Sector in Colombia.

The purpose of this report is to, firstly, give a comparative overview of the biotechnology sector in Colombia and, secondly, provide an estimate of how an improvement to Colombia’s policy environment can result in higher biotechnology outputs including rates of biomedical FDI and clinical trials.

The report maps the current policy environment as it relates to biotechnology in Colombia and gives a detailed comparison on key major biotechnology ...

Continue Reading →
0

Pugatch Consilium launches 2016 BCI Survey

Posted by:

Pugatch Consilium has launched the third edition of the Biopharmaceutical Competitiveness & Investment (BCI) Survey: The Race for Biopharmaceutical Innovation.

A global executive opinion survey and index of economies’ attractiveness for biomedical investment, in 2016 the BCI covers 28 strategic markets and gauges individual markets in relation to others with similar levels of development. The study was released in Washington DC and Ottawa, Canada, with other local and regional launches to take place throughout the remainder of the year.

Key findings of the ...

Continue Reading →
0

Pugatch Consilium’s BCI Survey used at the BioBusiness Asia Conference

Posted by:

Pugatch Consilium’s Biopharmaceutical Competitiveness & Investment Survey – known as the BCI – gained much attention when presented by Taiwan’s Vice-President, Chien-Jen Chen in his opening remarks at the BioBusiness Asia Conference which took place last week in Taipei.

VP Chen discussed the growth and development of Taiwan’s biotech industry, the challenges that still remain, and the new governmental policies in six areas of priorities in the biomedical industry, including increased efforts to harmonize the IP and legislative environments with international ...

Continue Reading →
0

Pugatch Consilium releases new edition of Building the Bioeconomy – Shows how economies that are successful in building a high-tech biotechnology capacity put the right enabling policies in place

Posted by:

Commissioned by the Biotechnology Industry Organization and authored by Pugatch Consilium this series of reports seek to provide an overview of those national innovation strategies, policies and best practices that have been successful in creating an environment in which biotechnologies and biotechnological innovation can flourish.

 

This year Building the Bioeconomy has grown from thirteen economies to sixteen, adding Colombia, Israel and Japan. As in previous editions the sample of economies is geographically and economically diverse with a mix of high-income mature ...

Continue Reading →
0

Separating Fact from Fiction – How Localization Barriers Fail Where Positive Non-discriminatory Incentives Succeed

Posted by:

More in number and more draconian – Localization barriers have grown in number and intensity over the last decade. Our new study – Separating Fact from Fiction: How Localization Barriers Fail Where Positive Non-discriminatory Incentives Succeed – finds that over the last 5-10 years industrial aspirations and concern over their dependence on global supply chains have led many emerging markets to seek to bolster or create indigenous sectors through introducing protectionist-like measures.

However, the study also finds that restrictive and punitive ...

Continue Reading →
0

Pugatch Consilium at the Mexican Senate and IMPI event on promoting economic development and industrial competitiveness in Mexico

Posted by:

Dr. David Torstensson spoke yesterday at the Mexican Senate and IMPI (the Mexican industrial property institute) event entitled: “First day for an original Mexico – promoting the culture of industrial property” (Primera Jornada por un México Original: Promoviendo la cultura de la propiedad industrial). With the aim of increasing awareness to the importance of IP protection to economic development, numerous representatives of public and private institutions analyzed the current state of the Mexican IP environment, with a particular focus on ...

Continue Reading →
0

Infinite Possibilities

Posted by:

Professor Meir Pugatch spoke at the launch of the fourth edition of the U.S. Chamber’s International IP Index. Titled: Infinite Possibilities, this edition maps and benchmarks the intellectual property environment in 38 economies, which together account for nearly 85% of global gross domestic product (GDP). On the whole, while challenges and setbacks still exist across the board, many of the benchmarked countries have taken positive steps and improved their IP environments. The Index also includes a special annex which underscores ...

Continue Reading →
0

Pugatch Consilium at the New Delhi conference on Expanding Healthcare Access in India

Posted by:

Last thursday January 14, 2016, Prof Meir Pugatch spoke at the groundbreaking conference entitled “Growing the Innovative Bio-pharmaceutical Industry and Expanding Healthcare Access in India” in New Delhi convened by the The U.S.-India Business Council (USIBC) in partnership with the Department of Industrial Policy and Promotion (DIPP) and the Investment and Technology Promotion Division (ITP) of the Ministry of External Affairs. During the session, Prof Pugatch presented the findings of one of Pugatch Consilium’s latest studies on India, highlighting how ...

Continue Reading →
0

The Next Frontier in Ensuring the Quality of Medicines: Maintaining International Quality and Safety Standards in the Manufacturing and Supply of Active Pharmaceutical Ingredients

Posted by:

Today Pugatch Consilium launches The Next Frontier in Ensuring the Quality of Medicines: Maintaining International Quality and Safety Standards in the Manufacturing and Supply of Active Pharmaceutical Ingredients. Authored by Professor Meir Pugatch, Dr. David Torstensson and Ma’ayan Laufer this report provides a deep-dive analysis of the next generation of challenges facing drug regulators across the globe.

Pharmacovigilance is the name given to the mechanisms and tests that together map and ensure the safety of a medicine throughout its life span ...

Continue Reading →
0
Page 4 of 15 «...23456...»